Each breakthrough in biomedical technology emphasises the accelerating rate of ‘science time’. The pace of scientific development has been directly promoted by substantial increases in OECD (Organisation for Economic Cooperation and Development) government funding for genetic and biotechnological research. Meanwhile, cohorts of government committees and individuals struggle with the scientific, ethical, legal and social implications of these advances in a slower ethics timeframe. Legislators, and in an increasing trend, judges, are having to develop or apply rules to avoid the perils and secure the promises of this new scientific age. This ‘law time’ operates within national boundaries, whereas science is quintessentially international.
Publisher version archived with the permission of the Dean, Division of Law, Macquarie University, NSW, Australia. This copy is available for individual, non-commercial use. Permission to reprint/republish this version for other uses must be obtained from the publisher.